We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAY
726
DELISTED
Bottomline Technologies Inc
EPAY
$3.3M 0.02%
62,582
-37,938
-38% -$1.72M
LAD icon
727
Lithia Motors
LAD
$7.88B
$3.28M 0.02%
+11,217
New +$3.07M
KRE icon
728
State Street SPDR S&P Regional Banking ETF
KRE
$4.47B
$3.28M 0.02%
+63,171
New +$2.89M
NSIT icon
729
Insight Enterprises
NSIT
$3.71B
$3.28M 0.02%
43,112
+18,647
+76% +$1.26M
WLY icon
730
John Wiley & Sons Class A
WLY
$2.59B
$3.27M 0.02%
+71,662
New +$2.6M
BFX
731
DELISTED
BowFlex Inc.
BFX
$3.27M 0.02%
+179,981
New +$3.74M
NOVT icon
732
Novanta
NOVT
$5.01B
$3.26M 0.02%
27,596
-46,473
-63% -$5.42M
CDLX icon
733
Cardlytics
CDLX
$21.7M
$3.24M 0.02%
+2,272
New +$2.42M
TALK icon
734
Talkspace
TALK
$874M
$3.24M 0.02%
299,998
JLL icon
735
Jones Lang LaSalle
JLL
$15.5B
$3.24M 0.02%
21,841
+3,917
+22% +$503K
KMB icon
736
Kimberly-Clark
KMB
$37B
$3.24M 0.02%
+24,002
New +$3.36M
PBI icon
737
Pitney Bowes
PBI
$2.46B
$3.23M 0.02%
524,015
+117,637
+29% +$707K
CNC icon
738
Centene
CNC
$31.6B
$3.22M 0.02%
+53,658
New +$3.41M
EVGO icon
739
EVgo
EVGO
$220M
$3.21M 0.02%
+299,994
New +$3.1M
JIH.WS
740
CALL
DELISTED
Juniper Industrial Holdings, Inc. Redeemable warrants included as part of the units
JIH.WS
$3.21M 0.02%
+299,994
New +$445K
CRS icon
741
Carpenter Technology
CRS
$28.8B
$3.2M 0.02%
109,871
+37,077
+51% +$859K
TINV.U
742
DELISTED
Tiga Acquisition Corp. Units, each consisting of one Class A ordinary share and one half of one warrant
TINV.U
$3.17M 0.02%
+300,000
New +$3.11M
DOV icon
743
Dover
DOV
$27.7B
$3.17M 0.02%
25,114
-6,265
-20% -$744K
AR icon
744
Antero Resources
AR
$10.5B
$3.17M 0.02%
+580,894
New +$2.38M
RCM
745
DELISTED
R1 RCM Inc. Common Stock
RCM
$3.16M 0.02%
131,529
-679,161
-84% -$13.5M
ENSG icon
746
The Ensign Group
ENSG
$10.4B
$3.16M 0.02%
+43,319
New +$2.87M
ENS icon
747
EnerSys
ENS
$6.94B
$3.15M 0.02%
37,934
-71,918
-65% -$5.64M
BP icon
748
BP
BP
$109B
$3.14M 0.02%
+153,147
New +$2.89M
SONO icon
749
Sonos
SONO
$1.87B
$3.14M 0.02%
+134,223
New +$2.5M
DAC icon
750
Danaos Corp
DAC
$2.55B
$3.14M 0.02%
146,333
+108,983
+292% +$1.4M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.